Currently, Aldeyra Therapeutics Inc [ALDX] is trading at $2.42, up 12.04%. An important factor to consider is whether the stock is rising or falling in short-term value. The ALDX shares have gain 9.50% over the last week, with a monthly amount glided 10.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Aldeyra Therapeutics Inc [NASDAQ: ALDX] stock has seen the most recent analyst activity on April 03, 2024, when Oppenheimer upgraded its rating to a Outperform but kept the price target unchanged to $10 for it. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $26 on February 08, 2021. Berenberg initiated its recommendation with a Buy and recommended $32 as its price target on December 16, 2020. Jefferies started tracking with a Buy rating for this stock on October 30, 2020, and assigned it a price target of $24. In a note dated October 16, 2020, BTIG Research initiated an Buy rating and provided a target price of $29 on this stock.
This stock has fluctuated between a low of $1.14 and a high of $7.20 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $11 within the next 12 months. Aldeyra Therapeutics Inc [NASDAQ: ALDX] shares were valued at $2.42 at the most recent close of the market. An investor can expect a potential return of 354.55% based on the average ALDX price forecast.
Analyzing the ALDX fundamentals
Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at -42643766.81%, Pretax Profit Margin comes in at -40607333.25%, and Net Profit Margin reading is -40607333.25%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.62 and Total Capital is -0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Aldeyra Therapeutics Inc [NASDAQ:ALDX] is 6.39. On the other hand, the Quick Ratio is 6.39, and the Cash Ratio is 3.52.
Transactions by insiders
Recent insider trading involved PERCEPTIVE ADVISORS LLC, 10% Owner, that happened on Apr 03 ’25 when 3.4 million shares were sold. Chief Development Officer, Machatha Stephen completed a deal on Aug 12 ’24 to sell 16041.0 shares. Meanwhile, Greenberg Bruce sold 10834.0 shares on Aug 12 ’24.
